SK133997A3 - Derivatives of ascomycin, method for the preparation thereof and pharmaceutical composition containing the same - Google Patents
Derivatives of ascomycin, method for the preparation thereof and pharmaceutical composition containing the same Download PDFInfo
- Publication number
- SK133997A3 SK133997A3 SK1339-97A SK133997A SK133997A3 SK 133997 A3 SK133997 A3 SK 133997A3 SK 133997 A SK133997 A SK 133997A SK 133997 A3 SK133997 A3 SK 133997A3
- Authority
- SK
- Slovakia
- Prior art keywords
- compound
- group
- compound according
- groups
- carboxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/18—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9507128.8A GB9507128D0 (en) | 1995-04-06 | 1995-04-06 | Organic compounds |
GBGB9526050.1A GB9526050D0 (en) | 1995-12-20 | 1995-12-20 | Organic compounds |
GBGB9526049.3A GB9526049D0 (en) | 1995-12-20 | 1995-12-20 | Organic compounds |
PCT/EP1996/001492 WO1996031514A1 (en) | 1995-04-06 | 1996-04-04 | Ascomycins |
Publications (1)
Publication Number | Publication Date |
---|---|
SK133997A3 true SK133997A3 (en) | 1998-05-06 |
Family
ID=27267660
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK1339-97A SK133997A3 (en) | 1995-04-06 | 1996-04-04 | Derivatives of ascomycin, method for the preparation thereof and pharmaceutical composition containing the same |
Country Status (21)
Country | Link |
---|---|
US (1) | US5925649A (es) |
EP (1) | EP0819130A1 (es) |
JP (1) | JP2000505044A (es) |
KR (1) | KR19980703583A (es) |
CN (1) | CN1088068C (es) |
AR (1) | AR004480A1 (es) |
AU (1) | AU703523B2 (es) |
BR (1) | BR9604808A (es) |
CA (1) | CA2216562A1 (es) |
CO (1) | CO4750668A1 (es) |
CZ (1) | CZ312397A3 (es) |
FI (1) | FI973529A (es) |
HU (1) | HUP9801993A3 (es) |
IL (1) | IL117815A (es) |
MX (1) | MX9707636A (es) |
NO (1) | NO309273B1 (es) |
NZ (1) | NZ307170A (es) |
PL (1) | PL322553A1 (es) |
SK (1) | SK133997A3 (es) |
TR (1) | TR199700999T1 (es) |
WO (1) | WO1996031514A1 (es) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MEP30008A (en) | 1998-03-26 | 2010-10-10 | Astellas Pharma Inc | Sustained release preparations |
GB9826656D0 (en) | 1998-12-03 | 1999-01-27 | Novartis Ag | Organic compounds |
US6121257A (en) * | 1999-03-31 | 2000-09-19 | Abbott Laboratories | Sulfamate containing macrocyclic immunomodulators |
DE60015516T2 (de) * | 1999-04-30 | 2005-12-01 | Sucampo Ag | Verwendung von makroliden zur behandlung von trockenen augen |
US7063857B1 (en) | 1999-04-30 | 2006-06-20 | Sucampo Ag | Use of macrolide compounds for the treatment of dry eye |
AU769315B2 (en) | 1999-08-24 | 2004-01-22 | Cellgate, Inc. | Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties |
AR033151A1 (es) * | 2001-04-12 | 2003-12-03 | Sucampo Pharmaceuticals Inc | Agente para el tratamiento oftalmico topico de las enfermedades inflamatorias oculares |
US20030119797A1 (en) * | 2001-05-09 | 2003-06-26 | Salah-Dine Chibout | Methods for selective immunomodulation |
AU2003283399B2 (en) * | 2002-11-15 | 2007-04-19 | Novartis Ag | Drug delivery system |
US20060115522A1 (en) * | 2003-02-17 | 2006-06-01 | Cipla Ltd | Pharmaceutical composition |
TWI324604B (en) * | 2003-06-18 | 2010-05-11 | Novartis Ag | New use of staurosporine derivatives |
US7780973B2 (en) * | 2003-12-15 | 2010-08-24 | Ethicon Endo-Surgery, Inc. | Method and device for minimally invasive implantation of biomaterial |
CA2552305A1 (en) * | 2003-12-30 | 2005-07-14 | Astellas Pharma Inc. | Use of macrolides for treating or preventing airflow obstruction |
US20050142161A1 (en) * | 2003-12-30 | 2005-06-30 | Freeman Lynetta J. | Collagen matrix for soft tissue augmentation |
WO2006082588A2 (en) * | 2005-02-07 | 2006-08-10 | Pharmalight Inc. | Method and device for ophthalmic administration of active pharmaceutical ingredients |
US10143682B2 (en) | 2014-10-28 | 2018-12-04 | Koushi Yamaguchi | Medicine for improving state of pregnancy, and use thereof |
JP7465806B2 (ja) | 2018-08-10 | 2024-04-11 | 晃史 山口 | 母体と胎児との関係における液性免疫関連疾患の治療薬 |
AU2019401108A1 (en) | 2018-12-18 | 2021-07-01 | Koushi Yamaguchi | Agent for improving infertility, recurrent miscarriage, and state of pregnancy |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3244592A (en) * | 1962-06-09 | 1966-04-05 | Arai Tadashi | Ascomycin and process for its production |
US4894366A (en) * | 1984-12-03 | 1990-01-16 | Fujisawa Pharmaceutical Company, Ltd. | Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same |
JPS6317884A (ja) * | 1986-05-30 | 1988-01-25 | Fujisawa Pharmaceut Co Ltd | トリシクロ化合物 |
JPH01125394A (ja) * | 1987-11-10 | 1989-05-17 | Mect Corp | シアロシルグリセロリピッド類及びその製造方法 |
EP0346427B1 (en) * | 1987-12-09 | 1995-03-29 | FISONS plc | Macrocyclic compounds |
EP0487593A1 (en) * | 1989-08-18 | 1992-06-03 | FISONS plc | Macrocyclic compounds |
KR0159766B1 (ko) * | 1989-10-16 | 1998-12-01 | 후지사와 토모키치로 | 양모제 조성물 |
AU640963B2 (en) * | 1989-11-09 | 1993-09-09 | MEDA Pharma S.a.r.l | Heteroatoms-containing tricyclic compounds |
JPH05504956A (ja) * | 1990-03-12 | 1993-07-29 | 藤沢薬品工業株式会社 | トリシクロ化合物 |
WO1991019495A1 (en) * | 1990-06-11 | 1991-12-26 | Fujisawa Pharmaceutical Co., Ltd. | Use of a macrolide compound such as fk 506 for manufacturing a medicament for treating idiopathic thrombocytopenic purpura and basedow's disease |
MY110418A (en) * | 1990-07-02 | 1998-05-30 | Novartis Ag | Heteroatoms-containing tricyclic compounds. |
DE69125230T2 (de) * | 1990-09-04 | 1997-07-10 | Fujisawa Pharmaceutical Co | Tricyclische Verbindungen enthaltende Salben |
IE65341B1 (en) * | 1990-11-08 | 1995-10-18 | Fujisawa Pharmaceutical Co | Suspensions containing tricyclic compounds |
US5247076A (en) * | 1991-09-09 | 1993-09-21 | Merck & Co., Inc. | Imidazolidyl macrolides having immunosuppressive activity |
US5252732A (en) * | 1991-09-09 | 1993-10-12 | Merck & Co., Inc. | D-heteroaryl, O-alkylheteroaryl, O-alkenylheteroaryl and O-alkynylheteroarylmacrolides having immunosuppressive activity |
US5208241A (en) * | 1991-09-09 | 1993-05-04 | Merck & Co., Inc. | N-heteroaryl, n-alkylheteroaryl, n-alkenylheteroaryl and n-alkynylheteroarylmacrolides having immunosuppressive activity |
US5457194A (en) * | 1993-03-17 | 1995-10-10 | Abbott Laboratories | Substituted aliphatic amine-containing macrocyclic immunomodulators |
EP0786986B1 (en) * | 1994-10-26 | 2002-03-20 | Novartis AG | Use of an unsaturated fatty alcohol |
-
1996
- 1996-04-02 AR ARP960102027A patent/AR004480A1/es unknown
- 1996-04-03 CO CO96016454A patent/CO4750668A1/es unknown
- 1996-04-03 IL IL11781596A patent/IL117815A/xx not_active IP Right Cessation
- 1996-04-04 PL PL96322553A patent/PL322553A1/xx unknown
- 1996-04-04 CA CA002216562A patent/CA2216562A1/en not_active Abandoned
- 1996-04-04 EP EP96913486A patent/EP0819130A1/en not_active Withdrawn
- 1996-04-04 BR BR9604808A patent/BR9604808A/pt active Search and Examination
- 1996-04-04 US US08/930,730 patent/US5925649A/en not_active Expired - Fee Related
- 1996-04-04 CN CN96193091A patent/CN1088068C/zh not_active Expired - Fee Related
- 1996-04-04 HU HU9801993A patent/HUP9801993A3/hu unknown
- 1996-04-04 WO PCT/EP1996/001492 patent/WO1996031514A1/en not_active Application Discontinuation
- 1996-04-04 JP JP8529996A patent/JP2000505044A/ja active Pending
- 1996-04-04 AU AU56453/96A patent/AU703523B2/en not_active Ceased
- 1996-04-04 CZ CZ973123A patent/CZ312397A3/cs unknown
- 1996-04-04 NZ NZ307170A patent/NZ307170A/xx unknown
- 1996-04-04 SK SK1339-97A patent/SK133997A3/sk unknown
- 1996-04-04 TR TR97/00999T patent/TR199700999T1/xx unknown
- 1996-04-04 KR KR1019970706988A patent/KR19980703583A/ko not_active Application Discontinuation
-
1997
- 1997-08-27 FI FI973529A patent/FI973529A/fi unknown
- 1997-10-01 NO NO974536A patent/NO309273B1/no not_active IP Right Cessation
- 1997-10-03 MX MX9707636A patent/MX9707636A/es not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0819130A1 (en) | 1998-01-21 |
MX9707636A (es) | 1998-06-30 |
CN1180359A (zh) | 1998-04-29 |
IL117815A (en) | 2000-07-16 |
AU703523B2 (en) | 1999-03-25 |
CO4750668A1 (es) | 1999-03-31 |
TR199700999T1 (xx) | 1998-01-21 |
NO974536L (no) | 1997-10-01 |
HUP9801993A2 (hu) | 1998-12-28 |
CN1088068C (zh) | 2002-07-24 |
CA2216562A1 (en) | 1996-10-10 |
FI973529A0 (fi) | 1997-08-27 |
FI973529A (fi) | 1997-11-25 |
CZ312397A3 (cs) | 1998-01-14 |
KR19980703583A (ko) | 1998-11-05 |
HUP9801993A3 (en) | 2000-04-28 |
US5925649A (en) | 1999-07-20 |
NZ307170A (en) | 1999-03-29 |
IL117815A0 (en) | 1996-08-04 |
AR004480A1 (es) | 1998-12-16 |
WO1996031514A1 (en) | 1996-10-10 |
AU5645396A (en) | 1996-10-23 |
BR9604808A (pt) | 1998-06-09 |
NO309273B1 (no) | 2001-01-08 |
JP2000505044A (ja) | 2000-04-25 |
PL322553A1 (en) | 1998-02-02 |
NO974536D0 (no) | 1997-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SK133997A3 (en) | Derivatives of ascomycin, method for the preparation thereof and pharmaceutical composition containing the same | |
US5486523A (en) | Carbamates of rapamycin | |
US9499849B2 (en) | Processes for preparing tubulysins | |
US5488054A (en) | Carbamates of Rapamycin | |
US6294517B1 (en) | Compositions and kits comprising alpha-adrenergic receptor antagonists and nitric oxide donors and methods of use | |
US20060247216A1 (en) | Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments | |
JP2002523450A (ja) | ニトロソ化およびニトロシル化されたホスホジエステラーゼ阻害剤、組成物および使用方法 | |
PL207636B1 (pl) | Produkt sprzężenia związku makrolidowego specyficznego wobec komórek immunokompetentnych ze związkiem o działaniu przeciwzapalnym i jego zastosowanie | |
RO107656B1 (ro) | Derivati de beta-carbonil-carboxiamide ale 1,3-tiazolidinelor si procedeu pentru prepararea acestora | |
US5266566A (en) | Method of treating fungal infections using sterodial ester compounds | |
RU2173688C2 (ru) | Аскомицины, способ их получения и фармацевтическая композиция на их основе | |
SK14812001A3 (sk) | Maduraftalazínové deriváty a ich použitie ako inhibítorov prozápalových cytokínov | |
JP2003512450A (ja) | 可溶性ヒトcd23形成阻害剤としてのヒドロキサム酸誘導体 | |
JP3956188B2 (ja) | プリン誘導体2水和物、それを有効成分として含む医薬およびその製造中間体 | |
US8012993B2 (en) | Stable S-nitrosothiols, method of synthesis and use | |
US4609657A (en) | Ergot peptide alkaloid derivatives, processes for their preparation and pharmaceutical compositions containing them | |
JP2024063194A (ja) | マクロライド化合物及びその慢性呼吸器疾患の治療用途 | |
HU210248B (en) | Process for preparing 3-l-(5-thioxo-l-prolyl)-thiazolidine-4-carboxylic acid, derivatives thereof and pharmaceutical compositions containing them | |
JP2014091677A (ja) | キチナーゼ阻害剤 | |
IE904627A1 (en) | Methods of using 2-isopropyl-2-phenylaminovaleronitriles immunosuppressants and vasodilators | |
JP2016527280A (ja) | ジフェニルオキシアルキルアミン誘導体およびアリールオキシアルキルアミン誘導体、薬学的組成物、慢性肺炎症性疾患を治療、予防、または阻止するための前記薬学的組成物の使用、ならびにそのような疾患を治療または予防するための方法 |